Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-Omics Integrated Analysis.
Chinese medicine
chronic hepatitis B
metabolomics
tongue diagnosis
transcriptomic
Journal
Chinese journal of integrative medicine
ISSN: 1993-0402
Titre abrégé: Chin J Integr Med
Pays: China
ID NLM: 101181180
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
accepted:
17
04
2020
pubmed:
12
9
2020
medline:
31
12
2021
entrez:
11
9
2020
Statut:
ppublish
Résumé
To compare the circular pathological changes of chronic hepatitis B (CHB) patients according to the tongue diagnosis. Totally 41 CHB patients with typical white tongue coating (WTC) or yellow tongue coating (YTC) were enrolled and 14 healthy volunteers with normal tongue manifestation served as controls. The mRNA expression of peripheral leukocytes was detected by GeneChips, and 9 genes were randomly selected for expression validation. Circular metabolites were detected by gas chromatographymass spectrometry. Biological information was analyzed based on ingenuity pathways analysis or metabolomics database and the integrated networks were constructed by ClueGO. A total of 945 and 716 differentially expressed genes were found in patients with WTC and YTC relative to healthy volunteers respectively. The biological information analysis indicated that CHB patients had obviously increased functions in cell death, apoptosis and necrosis (Z-score ⩾2, P<0.05) and decreased activation in T lymphocytes (Z-score ⩽-2, P<0.05), regardless of the tongue manifestation. Compared to patients with WTC, the YTC patients were predicted to be more active in functions related to virus replication (Z-score ⩾2, P<0.05), and the content of circular fatty acids, such as oleic acid (P=0.098) and lauric acid (P=0.035), and citric acid cycle-related metabolites were higher in the YTC patients (P<0.1). The integrated analysis based on differential genes and metabolites indicated that the most difference in the biological function network between the WTC and YTC patients was tumor necrosis factor receptor associated factor 6 mediated-nuclear factor kappa-B activation process. CHB patients with YTC had more severe inflammation and fatty acids metabolism aberrant than patients with WTC. The results facilitate the modern pathological annotation of Chinese medicine tongue diagnosis theory and provide a reference for the interpretation of pharmacological mechanisms of Chinese medicine treatment.
Identifiants
pubmed: 32915427
doi: 10.1007/s11655-020-3275-4
pii: 10.1007/s11655-020-3275-4
doi:
Substances chimiques
Fatty Acids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
28-35Informations de copyright
© 2020. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet 2018;392:2313–2324.
doi: 10.1016/S0140-6736(18)31865-8
Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582–592.
doi: 10.1016/S0140-6736(09)60207-5
GBD Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–171.
doi: 10.1016/S0140-6736(14)61682-2
Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 2010;51:690–698.
doi: 10.1002/hep.23384
Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol 2000;15(Suppl):E67–E70.
doi: 10.1046/j.1440-1746.2000.02100.x
Tsai TY, Livneh H, Hung TH, Lin IH, Lu MC, Yeh CC. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study. BMJ Open 2017;7:e014571.
doi: 10.1136/bmjopen-2016-014571
Ye J, Cai X, Yang J, Sun X, Hu C, Xia J, et al. Bacillus as a potential diagnostic marker for yellow tongue coating. Sci Rep 2016;6:32496.
doi: 10.1038/srep32496
Sun ZM, Zhao J, Qian P, Wang YQ, Zhang WF, Guo CR, et al. Metabolic markers and microecological characteristics of tongue coating in patients with chronic gastritis. BMC Complement Altern Med 2013;13:227.
doi: 10.1186/1472-6882-13-227
Zhao Y, Mao YF, Tang YS, Ni MZ, Liu QH, Wang Y, et al. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings. World J Gastroenterol 2018;24:3448–3461.
doi: 10.3748/wjg.v24.i30.3448
Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Hepatol (Chin) 2011;19:13–24.
Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association. The standards of TCM differential syndromes of viral hepatitis. J Tradit Chin Med (Chin) 1992;5:39–40.
Zhao Y, Gou XJ, Dai JY, Peng JH, Feng Q, Sun SJ, et al. Differences in metabolites of different tongue coatings in patients with chronic hepatitis B. Evid Based Complement Alternat Med 2013;2013:204908.
pubmed: 23690837
pmcid: 3652181
Dai J, Sun S, Cao J, Zhao Y, Cao H, Zheng N, et al. Similar connotation in chronic hepatitis B and nonalcoholic fatty liver patients with dampness-heat syndrome. Evid Based Complement Alternat Med 2013;2013:793820.
pubmed: 23690853
pmcid: 3638589
Masson JJR, Billings HWW, Palmer CS. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities. Antivir Chem Chemother 2017;25:53–57.
doi: 10.1177/2040206617701372
Yang L, Yang X, Kong X, Cao Z, Zhang Y, Hu Y, et al. Covariation analysis of serumal and urinary metabolites suggests aberrant glycine and fatty acid metabolism in chronic hepatitis B. PLoS One 2016;11:e0156166.
doi: 10.1371/journal.pone.0156166
Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPAR γ. Gastroenterology 2007;132:1955–1967.
doi: 10.1053/j.gastro.2007.03.039
Yang F, Yan S, He Y, Wang F, Song S, Guo Y, et al. Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J Hepatol 2008;48:12–19.
doi: 10.1016/j.jhep.2007.06.021
Luo G, Kim SJ, Khan M, Quan J, Till A, Subramani S, et al. Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathogens 2013;9:e1003722.
doi: 10.1371/journal.ppat.1003722
Schoeman JC, Hou J, Harms AC, Vreeken RJ, Berger R, Hankemeier T, et al. Metabolic characterization of the natural progression of chronic hepatitis B. Genome Medicine 2016;8:1–13.
doi: 10.1186/s13073-016-0318-8
Sunami Y, Ringelhan M, Kokai E, Lu M, O’Connor T, Lorentzen A, et al. Canonical NF- κ B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 2016;63:1592–1607.
doi: 10.1002/hep.28435
Namineni S, O’Connor T, Faure-Dupuy S, Johansen P, Riedl T, Liu K, et al. A dual role for hepatocyte-intrinsic canonical NF- κ B signaling in virus control. J Hepatology 2020;72:5.
doi: 10.1016/j.jhep.2019.12.019
Song H, Tan G, Yang Y, Cui A, Li H, Li T, et al. Hepatitis B virus-induced imbalance of inflammatory and antiviral signaling by differential phosphorylation of STAT1 in human monocytes. J Immunol 2019;202:2266–2275.
doi: 10.4049/jimmunol.1800848
Zou ZQ, Zhang S, Lin Q, Qu RL, Li YF, Zhang FH, et al. Immune response- and viral control-related pathways in the progression of chronic hepatitis B. Microb Pathogen 2017;105:100–105.
doi: 10.1016/j.micpath.2017.02.015
Li JY, Cao HY, Sun L, Sun RF, Wu C, Bian YQ, et al. Therapeutic mechanism of Yin-Chen-Hao Decoction in hepatic diseases. World J Gastroenterol 2017;23:1125–1138.
doi: 10.3748/wjg.v23.i7.1125
Cai FF, Bian YQ, Wu R, Sun Y, Chen XL, Yang MD, et al. Yinchenhao Decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacother 2019;114:108863.
doi: 10.1016/j.biopha.2019.108863
He F, Sun K, Peng J. Study on the functions of peripheral dendritic cells in chronic hepatitis B virus infection patients of Gan-depression Pi-deficiency syndrome and Gan-Dan dampness-heat syndrome under different immune states. Chin J Integr Trad West Med (Chin) 2011;31:1491–1495.
Zhao L, Wang L, Yan Y, Quan Z, Li Y, Ding Y. Correlation of chronic hepatitis B of dampness-heat resistance syndrome and Liver qi stagnation and Spleen deficiency syndrome with experimental index such as dendritic cell surface molecules and HBV-DNA viral load. Shanxi Med J (Chin) 2016;45:2222–2225.
van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HGM, Kusters JG, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004;40:738–746.
doi: 10.1002/hep.20366
Sun HH, Zhou DF, Zhou JY. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation. J Med Virol 2016;88:13–20.
doi: 10.1002/jmv.24306
Pearce EJ, Everts B. Dendritic cell metabolism. Nature Rev Immunol 2014;15:18–29.
doi: 10.1038/nri3771
Everts B, Amiel E, Huang SCC, Smith AM, Chang CH, Lam WY, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK ε supports the anabolic demands of dendritic cell activation. Nat Immunol 2014;15:323–332.
doi: 10.1038/ni.2833
Rehman A, Hemmert KC, Ochi A, Jamal M, Henning JR, Barilla R, et al. Role of fatty-acid synthesis in dendritic cell generation and function. J Immunol 2013;190:4640–4649.
doi: 10.4049/jimmunol.1202312